Pharma & Biotech
You will receive alerts when there are new announcements on Imugene Ltd
Only registered members can use this feature.
Imugene Ltd (ASX:IMU) is listed on the Australian Securities Exchange.
The company is well-funded to deliver on commercial and clinical milestones including the development of CF33, PD1-Vaxx and HER-Vaxx treatments.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.